vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and KENNAMETAL INC (KMT). Click either name above to swap in a different company.
KENNAMETAL INC is the larger business by last-quarter revenue ($529.5M vs $284.0M, roughly 1.9× ACADIA PHARMACEUTICALS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 6.4%, a 89.9% gap on every dollar of revenue. On growth, KENNAMETAL INC posted the faster year-over-year revenue change (9.8% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 1.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Kennametal, Inc. is a manufacturer of high-performance cutting tools and engineered components used in the aerospace, defense, transportation and oil and gas drilling industries. Its customer base is global.
ACAD vs KMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $529.5M |
| Net Profit | $273.6M | $33.9M |
| Gross Margin | 90.8% | 32.8% |
| Operating Margin | 6.1% | 9.9% |
| Net Margin | 96.3% | 6.4% |
| Revenue YoY | 9.4% | 9.8% |
| Net Profit YoY | 90.3% | 89.0% |
| EPS (diluted) | $1.61 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | $529.5M | ||
| Q3 25 | $278.6M | $498.0M | ||
| Q2 25 | $264.6M | $516.4M | ||
| Q1 25 | $244.3M | $486.4M | ||
| Q4 24 | $259.6M | $482.1M | ||
| Q3 24 | $250.4M | $481.9M | ||
| Q2 24 | $242.0M | $543.3M | ||
| Q1 24 | $205.8M | $515.8M |
| Q4 25 | $273.6M | $33.9M | ||
| Q3 25 | $71.8M | $23.3M | ||
| Q2 25 | $26.7M | $21.6M | ||
| Q1 25 | $19.0M | $31.5M | ||
| Q4 24 | $143.7M | $17.9M | ||
| Q3 24 | $32.8M | $22.1M | ||
| Q2 24 | $33.4M | $37.2M | ||
| Q1 24 | $16.6M | $19.0M |
| Q4 25 | 90.8% | 32.8% | ||
| Q3 25 | 92.2% | 31.0% | ||
| Q2 25 | 92.2% | 28.2% | ||
| Q1 25 | 91.7% | 32.1% | ||
| Q4 24 | 91.6% | 30.1% | ||
| Q3 24 | 92.5% | 31.3% | ||
| Q2 24 | 92.5% | 31.5% | ||
| Q1 24 | 88.8% | 29.7% |
| Q4 25 | 6.1% | 9.9% | ||
| Q3 25 | 12.8% | 7.5% | ||
| Q2 25 | 12.2% | 6.1% | ||
| Q1 25 | 7.9% | 9.1% | ||
| Q4 24 | 59.1% | 6.6% | ||
| Q3 24 | 12.6% | 7.5% | ||
| Q2 24 | 12.6% | 11.3% | ||
| Q1 24 | 7.4% | 6.8% |
| Q4 25 | 96.3% | 6.4% | ||
| Q3 25 | 25.8% | 4.7% | ||
| Q2 25 | 10.1% | 4.2% | ||
| Q1 25 | 7.8% | 6.5% | ||
| Q4 24 | 55.4% | 3.7% | ||
| Q3 24 | 13.1% | 4.6% | ||
| Q2 24 | 13.8% | 6.8% | ||
| Q1 24 | 8.0% | 3.7% |
| Q4 25 | $1.61 | $0.44 | ||
| Q3 25 | $0.42 | $0.30 | ||
| Q2 25 | $0.16 | $0.28 | ||
| Q1 25 | $0.11 | $0.41 | ||
| Q4 24 | $0.86 | $0.23 | ||
| Q3 24 | $0.20 | $0.28 | ||
| Q2 24 | $0.20 | $0.47 | ||
| Q1 24 | $0.10 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $129.3M |
| Total DebtLower is stronger | — | $597.2M |
| Stockholders' EquityBook value | $1.2B | $1.3B |
| Total Assets | $1.6B | $2.6B |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | $129.3M | ||
| Q3 25 | $258.0M | $103.5M | ||
| Q2 25 | $253.6M | $140.5M | ||
| Q1 25 | $217.7M | $97.5M | ||
| Q4 24 | $319.6M | $121.2M | ||
| Q3 24 | $155.1M | $119.6M | ||
| Q2 24 | $177.1M | $128.0M | ||
| Q1 24 | $204.7M | $92.1M |
| Q4 25 | — | $597.2M | ||
| Q3 25 | — | $597.0M | ||
| Q2 25 | — | $596.8M | ||
| Q1 25 | — | $596.6M | ||
| Q4 24 | — | $596.4M | ||
| Q3 24 | — | $596.2M | ||
| Q2 24 | — | $596.0M | ||
| Q1 24 | — | $595.8M |
| Q4 25 | $1.2B | $1.3B | ||
| Q3 25 | $917.3M | $1.3B | ||
| Q2 25 | $822.4M | $1.3B | ||
| Q1 25 | $765.2M | $1.2B | ||
| Q4 24 | $732.8M | $1.2B | ||
| Q3 24 | $577.2M | $1.3B | ||
| Q2 24 | $516.7M | $1.2B | ||
| Q1 24 | $464.0M | $1.3B |
| Q4 25 | $1.6B | $2.6B | ||
| Q3 25 | $1.3B | $2.5B | ||
| Q2 25 | $1.2B | $2.5B | ||
| Q1 25 | $1.1B | $2.5B | ||
| Q4 24 | $1.2B | $2.4B | ||
| Q3 24 | $976.9M | $2.5B | ||
| Q2 24 | $914.1M | $2.5B | ||
| Q1 24 | $855.1M | $2.5B |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.49× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.47× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $55.1M |
| Free Cash FlowOCF − Capex | — | $42.4M |
| FCF MarginFCF / Revenue | — | 8.0% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | -0.18× | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | — | $99.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | $55.1M | ||
| Q3 25 | $74.3M | $17.5M | ||
| Q2 25 | $64.0M | $78.6M | ||
| Q1 25 | $20.3M | $28.8M | ||
| Q4 24 | $40.4M | $55.2M | ||
| Q3 24 | $63.2M | $45.7M | ||
| Q2 24 | $25.0M | $113.6M | ||
| Q1 24 | $29.1M | $75.2M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | $73.9M | $-5.5M | ||
| Q2 25 | — | $57.1M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $35.9M | ||
| Q3 24 | $63.2M | $21.0M | ||
| Q2 24 | — | $90.3M | ||
| Q1 24 | — | $48.4M |
| Q4 25 | — | 8.0% | ||
| Q3 25 | 26.5% | -1.1% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | 25.2% | 4.4% | ||
| Q2 24 | — | 16.6% | ||
| Q1 24 | — | 9.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | 0.1% | 4.6% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | 0.0% | 5.1% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | -0.18× | 1.63× | ||
| Q3 25 | 1.03× | 0.75× | ||
| Q2 25 | 2.40× | 3.64× | ||
| Q1 25 | 1.07× | 0.92× | ||
| Q4 24 | 0.28× | 3.08× | ||
| Q3 24 | 1.93× | 2.07× | ||
| Q2 24 | 0.75× | 3.06× | ||
| Q1 24 | 1.76× | 3.96× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
KMT
| Metal Cutting | $331.1M | 63% |
| Infrastructure | $198.5M | 37% |
